NEW YORK (GenomeWeb News) - Proteomics company CS-Keys said yesterday that it has received a "significant" but undisclosed seed investment from Midwest VC firm Triathlon Medical Ventures.
CS-Keys, based in Indianapolis, will use the investment to continue researching and developing its cancer-specific biomarkers and supporting its marketing and regulatory strategies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.